Healthcare Rap
How Noom Is Reducing GLP-1 Side Effects (#454)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:30:34
- Mas informaciones
Informações:
Sinopsis
Noom CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler highlight early results from the company’s microdosing program, the changes that happen as GLP-1's continue to dominate much of the public conversation about weight loss, and what physicians think about it all. All that, plus the Flava of the Week about leadership changes at CVS Health. Who is in, who is out, and what do the changes signal about the retail giant’s direction in the near term? SPOTLIGHT: FRIDAYS Lose weight with GLP-1 + GIP treatment, lifestyle coaching, and full support, for one transparent price. Everything you need to achieve lasting results: medical guidance, personalized coaching, insurance assistance, and a supportive community. No surprises. No fine print. Get your custom plan today: www.joinfridays.com/?utm_source=referral&utm_medium=podcast&utm_campaign=healthcare_rap JOIN THE COMMUNITY This show is produced by the Healthcare Rap Community. Come learn how to bridge the gap